ALFAXONE

This brand name is authorized in Nigeria.

Active ingredients

The drug ALFAXONE contains one active pharmaceutical ingredient (API):

1
UNII 75J73V1629 - CEFTRIAXONE
 

Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.

 
Read more about Ceftriaxone

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B4-0662 Injection ALFAXONE INJECTION INJ 1000 mg 1 VIAL + 9.6ML SWFI 45 RNW-PP-88496 ALFAXONE INJECTION CEFTRIAXONE 1G CEFTRIAXONE 1G B4-0662 Drugs Imported Products 1 VIAL + 9.6ML SWFI Prescription Only Medicine (POM) 7/24/2023 ALPHA PHARMACY AND STORES NIG LIMITED, ALABI STREET OFF TOYIN STREET, ALLEN AVENUE, IKEJA IKEJA LAGOS 8023130690 alphapharmacyltd@yahoo.com KILITCH DRUGS (1) LTD, C-301/2, T.T.C. MIDC PAWANE VILLAGE THANE 400705 MAHARASHTRA STATE, INDIA., India 30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J01DD04 Ceftriaxone J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B4-0662

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.